PubRank

A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Clinical Trial ID NCT02587806

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02587806

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999 4.41
2 A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002 3.74
3 The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006 2.80
4 Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol 2014 2.51
5 The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006 2.47
6 Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009 2.43
7 Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach. Ann Neurol 2009 2.18
8 Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000 2.08
9 Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J Neurol Sci 2008 1.90
10 Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 1999 1.81
11 Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 1997 1.72
12 Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med 2010 1.53
13 Brain atrophy and lesion load predict long term disability in multiple sclerosis. J Neurol Neurosurg Psychiatry 2013 1.26
14 Historical and clinical perspectives of the expanded disability status scale. Neuroepidemiology 2008 1.18
15 MRI correlates of cognitive impairment in childhood-onset multiple sclerosis. Neuropsychology 2011 1.02
16 Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis. Mult Scler 2010 0.95
17 MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b. Neurology 2003 0.93
18 The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients. Mult Scler 2013 0.91
19 International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology 2013 0.89
20 Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials? Mult Scler 2009 0.85
21 T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation. Mult Scler 1998 0.84
22 The curious incident of disability in multiple sclerosis trials. Lancet Neurol 2006 0.83
23 Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis. Neurology 2007 0.82
Next 100